Shanghai RAAS Blood Products Co., Ltd. (002252) The Largest Beneficiary of Product Demand Differentiation

  • Contributor:TX Investment Consulting
  • Date:Feb 18, 2011
  • Pages:2pages
  • Price:$20.00
  • File Type: Adobe Acrobat Reader®
Download Free Adobe Acrobat Reader®

Research Reports Premium Services

-Get the full report for $20.00

-The financial products you have ordered will be sent to   you within 24 hours via e-mail.

Excerpts:

In blood product industry, undersupply and high-degree boom lead differentiation of terminal product demand. In 2010, plasma volume of the whole industry is 2950 ton, far from the supply and demand balance value of 5000 ton; with natural growth rate of 15%, supply and demand balance can’t be reached until at least 2014. Despite the high-degree boom, differentiation can’t be avoided.


SSL